Patents by Inventor Ja Hyoung Ryu

Ja Hyoung Ryu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fusion protein comprising glutathione-s-transferase and protein having binding affinity target cell or target protein, and use thereof
    Patent number: 11844844
    Abstract: Provided are a fusion protein including glutathione-S-transferase and a protein having binding affinity for a target cell or a target protein, and use thereof as a drug delivery carrier and a pharmaceutical composition. The fusion protein and the drug delivery carrier including the same according to an aspect may sustain an in vivo residence time, and may also have improved target cell-targeting ability, and thus may be effectively delivered to target cells. Accordingly, it may be usefully applied to a targeted therapeutic agent.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: December 19, 2023
    Assignee: UNIST(ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY)
    Inventors: Ja Hyoung Ryu, Joon Yong Oh, Han Sol Kim, Chae Kyu Kim, Se Byung Kang
  • Conjugate including peptide molecule capable of self-assembly in cell organelle and pharmaceutical composition for preventing or treating cancer including conjugate
    Patent number: 11083798
    Abstract: Disclosed are a conjugate including a mitochondria-targeting moiety and a peptide molecule capable of self-assembly; and a pharmaceutical composition for preventing or treating cancer including the conjugate as an active ingredient.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: August 10, 2021
    Assignee: Unist (Ulsan National Institute of Science and Technology)
    Inventors: Ja Hyoung Ryu, Manayath Thekkeyil Jeena
  • FUSION PROTEIN COMPRISING GLUTATHIONE-S-TRANSFERASE AND PROTEIN HAVING BINDING AFFINITY TARGET CELL OR TARGET PROTEIN, AND USE THEREOF
    Publication number: 20210000971
    Abstract: Provided are a fusion protein including glutathione-S-transferase and a protein having binding affinity for a target cell or a target protein, and use thereof as a drug delivery carrier and a pharmaceutical composition. The fusion protein and the drug delivery carrier including the same according to an aspect may sustain an in vivo residence time, and may also have improved target cell-targeting ability, and thus may be effectively delivered to target cells. Accordingly, it may be usefully applied to a targeted therapeutic agent.
    Type: Application
    Filed: November 28, 2018
    Publication date: January 7, 2021
    Applicant: UNIST(ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY)
    Inventors: Ja Hyoung Ryu, Joon Yong Oh, Han Sol Kim, Chae Kyu Kim, Se Byung Kang
  • CONJUGATE INCLUDING PEPTIDE MOLECULE CAPABLE OF SELF-ASSEMBLY IN CELL ORGANELLE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER INCLUDING CONJUGATE
    Publication number: 20180133330
    Abstract: Disclosed are a conjugate including a mitochondria-targeting moiety and a peptide molecule capable of self-assembly; and a pharmaceutical composition for preventing or treating cancer including the conjugate as an active ingredient.
    Type: Application
    Filed: November 15, 2017
    Publication date: May 17, 2018
    Applicant: UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY)
    Inventors: Ja Hyoung Ryu, Manayath Thekkeyil Jeena